Natriuretic peptides in intensive care medicine

被引：0

作者：

Grossmann, Stefan ^{[1
]}

Geisreiter, Florian ^{[1
]}

Schroll, Stephan ^{[1
]}

机构：

[1] Krankenhaus Barmherzige Bruder Regensburg, Klin Pneumol & konservat Intens Med, Regensburg, Germany

来源：

MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN | 2023年 / 118卷 / 07期

关键词：

BNP (B-type natriuretic peptide); NT-proBNP (N-terminal pro B-type natriuretic peptide); Laboratory diagnostics; Fluid management; Differential diagnosis; Cardiac function; ACUTE PULMONARY-EMBOLISM; SEPTIC SHOCK; MYOCARDIAL DYSFUNCTION; CARDIAC DYSFUNCTION; RISK STRATIFICATION; EJECTION FRACTION; RENAL-FUNCTION; HEART-FAILURE; SEVERE SEPSIS; BNP;

D O I：

10.1007/s00063-023-01002-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Natriuretic peptides must be interpreted in their clinical context, especially in intensive care medicine. This overview presents the diagnostic, prognostic, and therapeutic significance of B-type natriuretic peptide (BNP) and N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with cardiac dysfunction, kidney failure, sepsis, pulmonary embolism, acute respiratory distress syndrome (ARDS), acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and weaning from a respirator.

引用

页码：527 / 533

页数：7

共 50 条

[41] Natriuretic peptides in aortic stenosis [J].

Torres-Ramalho, Paulo ;

Araujo, Jose Paulo ;

Bettencourt, Paulo ;

Moura, Luis M. .

REVISTA PORTUGUESA DE CARDIOLOGIA, 2012, 31 (10) :655-660

[42] Natriuretic peptides in heart failure [J].

Krupicka, Jan ;

Janota, Tomas ;

Hradec, Jaromir .

COR ET VASA, 2013, 55 (04) :E370-E376

[43] Role of natriuretic peptides in heart failure The fine balance between precision medicine and the optimization of resources [J].

Baratta, Sergio J. ;

Nicolas Atamanuk, Andres ;

Carlos Santucci, Jose ;

Perrone, Sergio V. .

INSUFICIENCIA CARDIACA, 2021, 16 (03) :90-96

[44] Main points in intensive care medicine [J].

Brochard, L .

REVUE DE MEDECINE INTERNE, 2002, 23 (10) :847-852

[45] Levosimendan in cardiology and intensive care medicine [J].

Delle Karth, G ;

Heinz, G .

WIENER KLINISCHE WOCHENSCHRIFT, 2004, 116 (1-2) :6-14

[46] Phosphorylation mechanisms in intensive care medicine [J].

Martin, Erica L. ;

Ranieri, V. Marco .

INTENSIVE CARE MEDICINE, 2011, 37 (01) :7-18

[47] Thrombophilic states in intensive care medicine [J].

Engelmann, L. .

MEDIZINISCHE KLINIK, 2011, 106 (03) :189-197

[48] Updated Intensive Care Medicine from 2012-2014 [J].

Knapp, J. ;

Bernhard, M. ;

Hofer, S. ;

Popp, E. ;

Weigand, M. A. .

ANAESTHESIST, 2014, 63 (05) :429-438

[49] Hydroxyethyl starches in intensive care medicine: Status quo and perspectives [J].

Van Aken, H. ;

Roewer, N. ;

Noeldge-Schomburg, G. ;

Goetz, A. E. ;

Marx, G. ;

Zacharowski, K. .

ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2010, 51 :211-+

[50] Obesity and natriuretic peptides, BNP and NT-proBNP: Mechanisms and diagnostic implications for heart failure [J].

Madamanchi, Chaitanya ;

Alhosaini, Hassan ;

Sumida, Arihiro ;

Runge, Marschall S. .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (03) :611-617

← 1 2 3 4 5 →